ABSTRACT
INTRODUCTION
Testosterone in men is primarily produced by adult Leydig cells, and it is very important for the maintenance of spermatogenesis and secondary sexual characteristics. These cells differentiate from stem Leydig cells during puberty [1] . The pubertal development of adult Leydig cells can be divided into three stages in the rodent testes [2] [3] [4] : progenitor, immature, and adult Leydig cells. During puberty, the proliferation of Leydig cell precursors is required to increase the number of Leydig cells, with approximately 0.5 million Leydig cells per testis at Day 14 postpartum and approximately 3 million adult Leydig cells per testis in the mature mouse testis at Day 90 postpartum [4] .
Cholesterol is the substrate required for the final production of testosterone. The cholesterol in the Leydig cell is either from the extracellular source of cholesterol-containing lipoprotein via scavenger receptor class B member 1 (SR-BI; encoded by Scarb1) or from the de novo synthesis [2] . The adult Leydig cell responds to the stimulation of luteinizing hormone (LH), which binds to LH receptor (LHCGR) on its cell surface [2] . Under stimulation, the cholesterol is mobilized by steroidogenic acute regulatory protein (StAR; encoded by Star) to mitochondrial inner membrane, where it is catalyzed by cholesterol side-chain cleavage enzyme (CYP11A1) into pregnenolone [5] , and the latter diffuses into surrounding smooth endoplasmic reticulum, where a series of steroidogenic enzymes, including 3b-hydroxysteroid dehydrogenase (3b-HSD), 17a-hydroxylase/17,20-lyase (CYP17A1), and 17b-hydroxysteroid dehydrogenase 3 (17b-HSD3) are located. These enzymes sequentially catalyze their respective steroid substrates into the final product, testosterone [2] . Testosterone can also be metabolized by SRD5A1 and 3a-HSD in the Leydig cell precursors [2] .
The proliferation and differentiation of Leydig cell precursors is regulated by many factors. However, the underlying mechanism is still not fully understood. Cell cycle-regulating proteins have been shown to regulate both cell proliferation and differentiation [6] [7] [8] . One class of these cell cycle-regulating proteins is the cyclin-dependent kinase inhibitors (CDKIs), which regulate the actions of cyclin-dependent kinases (CDKs). The CDKIs consist of the Cip/Kip and INK4 families. Two Cip/Kip proteins, CDKN1A (also called p21 Cip1 ) and CDKN1B (also called p27 Kip1 ), are expressed in many cell types. CDKIs prevent progression from the G 1 phase to the S phase of the cell cycle. For example, increased expression of Cdkn1a or Cdkn1b blocks cell proliferation [6, 9] , and decreased expression of Cdkn1a or Cdkn1b leads to cell proliferation or the genesis of certain malignancies [6] .
In the mature testis, adult Leydig cells have been regarded as terminally differentiated. The absence of the cell cycleregulatory proteins CDKN1A or CDKN1B in the testis could interfere with Leydig cell differentiation. Indeed, CDKN1B has been demonstrated to be present in human and rodent Leydig cells [7, 10] . CDKN1A was also found to be present in TM3 and MA10 Leydig cells [11, 12] . Knockout , and DBKO mice were increased by 28%, 41%, and 85%, respectively [10, 13] . Accordingly, the daily sperm production in Cdkn1a
, and DBKO mice was also proportionally increased [13] . We previously demonstrated that serum testosterone concentrations were significantly reduced in Cdkn1b À/À mice, and this reduction was caused by the defect of Leydig cell differentiation [10] . It was found that several steroidogenic enzymes and cholesterol transport proteins were significantly reduced in the Cdkn1b À/À mouse testis, although Leydig cell numbers were increased [10] . Another study showed that the increased Cdkn1a expression after overexpression of aryl hydrocarbon receptor also led to the inhibition of growth in TM3 Leydig cells [11] . However, the exact role of Cdkn1a in the development and functions of Leydig cells is unclear. Therefore, in the present study, we examined the relative importance of Cdkn1a and Cdkn1b in regulation of Leydig cell proliferation and steroidogenesis using Cdkn1a À/À and DBKO mice.
MATERIALS AND METHODS

Animals
Cdkn1a null mutant mice (Cdkn1a
) are fertile, so Cdkn1a À/À mice were obtained by breeding knockouts. Wild-type (WT) and Cdkn1b null mutant mice (Cdkn1b À/À ) with background strain C57BL/6 were a gift from Dr. Hiro Kiyokawa (Feinberg School of Medicine, Northwestern University, Chicago, IL). DBKO mice were obtained by mating mice that were Cdkn1a þ/À and heterozygous for CDKN1B (Cdkn1b
). All mice were housed and bred in the College of Veterinary Medicine at the University of Illinois. Mice were housed five per cage under controlled environmental conditions (temperature, 22 6 28C; photoperiod, 12L:12D; lights-on, 0600-1800 h) and given water and a standard rodent diet ad libitum until they were euthanized at 90-120 days of age. Between 8 and 12 days of age, DNA was isolated from tail tissues using DirectPCR Lysis Reagent (Viagen Biotech, Inc.) and used to determine genotype as previously described [14] . All animals were handled to become adapted to the procedures for at least 3 days before the beginning of the experiment. All animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Illinois and conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Animal Handling
At 2 h before euthanization, all animals received an intraperitoneal injection of 5-bromo-2-deoxyuridine (BrdU; 40 lg/g body wt; Boehringer Mannheim GmbH) to label dividing cells. The animals were euthanized under deep anesthesia by intraperitoneal injection of sodium pentobarbital (25 mg/100 g body wt; Abbott Laboratories), and one testis from each animal was removed and frozen in liquid nitrogen for subsequent study of testicular testosterone levels and enzyme activity as well as Western blot analysis. The contralateral testis from each animal was fixed by whole-body perfusion through the left ventricle of the heart with Bouin solution [15] . After dehydration in ethanol and xylene, the testes were embedded in paraffin. Transverse sections were cut at a thickness of 5 lm and mounted on glass slides (Fisher Scientific Co.) for immunohistochemical analysis.
Determination of Leydig Cell Numbers and Proliferation Capacity
The Leydig cell was identified by staining for 3b-HSD. In brief, the avidinbiotin immunostaining was performed using kits (Vectastain, Elite, ABC Kit, PK-6101) from Vector Laboratories according to the manufacturer's instructions. Antigen retrieval was carried out by microwave irradiation for 10 min in 10 mM citrate buffer (pH 6.0), and endogenous peroxidase was blocked with 0.5% H 2 O 2 in methanol for 30 min. The sections were then incubated with a monoclonal anti-BrdU antibody (RPN 202; Amersham Biosciences) for 30 min at room temperature. The antibody bound to the nuclei was visualized with diaminobenzidine (catalog no. SK-4100; Vector Laboratories, Inc.), and the labeled nuclei were stained black by adding a nickel solution to the chromogen. After washing, the sections were double-labeled by incubation with a 3b-HSD polyclonal antibody diluted 1:1000 (provided by Dr. Van Luu-The, Laval University, Quebec City, QC, Canada) for 1 h at room temperature. The antibody-antigen complexes were visualized with diaminobenzidine alone, resulting in brown cytoplasmic staining in positively labeled Leydig cells. The sections were counterstained with Mayer hematoxylin, dehydrated in graded concentrations of alcohol, and cover-slipped with resin (Permount; Fisher Scientific). In control experiments, sections were incubated with nonimmune rabbit immunoglobulin (Ig) G (3b-HSD) or mouse IgG (BrdU) using the same working dilution as the primary antibody.
Stereology
Leydig number was determined by stereology using the fractionator method [16] . In brief, 15-20 randomly selected fields in each of three nonadjacent sections per testis were captured using a Nikon Eclipse E800 microscope. The total number of cells was calculated by multiplying the number of cells counted in a known fraction of the testis by the inverse of the sampling probability.
Computer-Assisted Image Analysis
Image analysis was performed as previously described [15, 17] . Dividing 
Real-Time Quantitative PCR
Total RNA was extracted from WT, Cdkn1a
À/À
, and DBKO mouse testes in TRIzol (Invitrogen) according to the manufacturer's instructions. The 12 genes analyzed, the primer designs, and their functional categories were as previously described [10] . Specifically, these 12 genes were Lhcgr (encoding LHCGR), Scarb1 (encoding SR-BI), Star (encoding StAR), Cyp11a1, Hsd3b6, Cyp17a1, Hsd17b3, Srd5a1, insulin-like growth factor 3 (Insl3, encoding INSL3), stem cell factor (Kitl), follicle-stimulating hormone receptor (Fshr, encoding FSHR), and proliferating cell nuclear antigen (Pcna, encoding PCNA). The RNA was reverse transcribed using random hexamers and Moloney Murine Leukemia Virus Reverse Transcriptase (Promega). The cDNA synthesis step and quantitative PCR (qPCR) were performed as previously described [18] . The RNA levels for the housekeeping gene ribosomal protein S16 (Rps16) were measured in all types of mice, and no significant changes were found between groups. Therefore, Rps16 was also assayed in all samples as an internal control. Messenger RNA measurements were normalized using a robust global normalization algorithm. All control crossing threshold values were corrected by the median difference in all samples from Rps16. The mRNA levels were calculated relative to Rps16 mRNA. The qPCR was carried out in a 25-ll volume with SYBR Green (Applied Biosystems). Reactions were carried out, and fluorescence was detected on a GeneAmp 5700 system (PE Applied Biosystems). The mRNA levels were adjusted by dividing the number of 3b-HSD-positive cells per 100 mg of testis (WT as 100%) calculated using stereology as above.
Testicular Testosterone Measurement
Testicular testosterone concentration was measured using a previously described method [10] . In brief, testes were homogenized, steroids extracted, and testicular testosterone detected using radioimmunoassay [10] . Values for interassay variation were 5%.
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Homogenization and Protein Content Assay
The testes were homogenized in 1 ml of ice-cold, 0.1 M PBS (pH 7.2) containing 0.25 M sucrose. Supernatants were collected by centrifugation at 700 3 g for 30 min, and the protein concentrations were determined using a kit (catalog no. 500-0006; Bio-Rad Laboratories, Inc.) with bovine serum albumin as a standard. The supernatants were used for Western blot analysis and enzymatic assay.
Western Blot Analysis
Western blot analysis was performed as previously described [19] . In brief, 40 lg of testis protein form each animal were used, and the following primary antibodies were adopted: StAR polyclonal rabbit antibody (1:1000; kindly donated by Dr. D.M. Stocco, Texas Tech University Health Sciences Center, Lubbock, TX), CYP11A1 polyclonal rabbit antibody (catalog no. RDIp450sccabr; RDI Research Diagnostics, Inc.), 3b-HSD polyclonal rabbit antibody (1:1000; ab65156; Abcam, Inc.), CYP17A1 rabbit polyclonal antiserum (1:1000; provided by Dr. D.B. Hales, University of Illinois, Chicago, IL), and 17b-HSD3 polyclonal goat antibody (1:1000; sc-66415; Santa Cruz Biotechnology, Inc.). The membranes were then washed and incubated with a 1:1000 dilution of secondary antibody that was conjugated to horseradish peroxidase (HRP; anti-rabbit IgG, HRP-linked whole antibody produced in goat and anti-goat IgG, or HRP-linked whole antibody produced in rabbit; Abcam, Inc.). The washing step was repeated, and immunoreactive bands were visualized by chemiluminescence using a kit (ECL; GE Healthcare UK). Then, the antibody in the membrane was stripped away and reprobed with rabbit polyclonal anti-actin antibody (1:1000; Cell Signaling Technology). Protein levels were measured by Kodak Image Station 4000 R (Eastman Kodak). The protein level was calculated relative to actin. The protein levels were adjusted by dividing the number of 3b-HSD-positive cells per 100 mg of testis (WT as 100%) calculated using stereology as above.
Enzyme Assays
Activities of the androgen biosynthetic enzymes 3b-HSD, CYP17A1, 17b-HSD3, and SRD5A1 were determined by thin-layer chromatography. In brief, the reaction mixtures (total volume, 250 ll), containing 50 lg of protein, 400 lM cofactors, and 50-100 nM radiolabeled steroid substrates (pregnenolone for 3b-HSD, progesterone for CYP17A1, androstenedione for 17b-HSD3, and testosterone for SRD5A1), were incubated in a shaking water bath at 348C for 60-120 min. The reaction rates were linear throughout the incubation period in the presence of 50 nM substrate. The steroids were extracted from the reaction mixture with 1 ml of ice-cold ether, and the organic layer was evaporated under nitrogen gas. The extract of steroids was resuspended in 70 ll of ether and then spotted on thin-layer plates (Baker-flex; J.T. Baker, Inc.). The steroids were separated chromatographically in chloroform and methanol (97:3, v/v) for 3b-HSD, 17b-HSD3, and SRD5A1 or in chloroform and ether (7:1, v/v) for CYP17A. The radioactivity was measured with a scanning radiometer (System 200/AC3000; Bioscan, Inc.). The conversion of substrates to products was calculated as a percentage of the total radioactivity found in the product. The enzymatic activities were adjusted by dividing the number of 3b-HSD positive cells per 100 mg of testis (WT as 100%) calculated using stereology as above.
Statistical Analysis
Data are expressed as the mean 6 SEM. Significant differences between WT, Cdkn1a À/À , and DBKO groups were identified by one-way ANOVA with ad hoc Tukey multiple-comparisons test using GraphPad Prism 6.0 (GraphPad Software). Differences were regarded as significant at P , 0.05.
RESULTS
Testis Weight, Leydig Cell Number, and Cell Size
We previously reported the significant increases of testis weight and Leydig cell number in the Cdkn1b À/À mouse (90% increase) [10] . As shown in Figure 1 , testis weights of the Cdkn1a À/À and DBKO mice were also increased by approximately 35% and 85%, respectively (Fig. 1A) . The Leydig cell was identified by immunohistochemical staining for 3b-HSD activity, and its number per testis was investigated using stereology. No change of Leydig cell number per testis was found in the Cdkn1a À/À mouse compared to the WT mouse; however, a significant increase of Leydig cell number per testis was observed in the DBKO mouse (Fig. 1B) . The Leydig cell number per testis in the DBKO mouse testis was comparable to that in the Cdkn1b À/À mouse [10] . When calculated per milligram testis, Leydig cell number was significantly lower in the Cdkn1a À/À testis, whereas this number in the DBKO testis was unchanged (Fig. 1C) . This indicates that the increase of testis mass in the Cdkn1a À/À testis is from non-Leydig cell types and that the increase of Leydig cell number in the DBKO testis is proportional to that in the other testicular cell types. The average cell diameter of the Leydig cell was not changed in both Cdkn1a À/À and DBKO mouse testes (Fig. 1D ).
Labeling Index of Leydig Cells
The Leydig cell was identified by immunohistochemical staining for 3b-HSD (brown color). BrdU labeling was used to identify the proliferative cell. The 3b-HSD and BrdU double staining was used to identify the proliferative Leydig cells (Fig.  2, A-C) . As shown in Figure 2D , the labeling index was unchanged in Cdkn1a À/À Leydig cells and significantly higher in the DBKO mouse testis when compared to the WT testis. The labeling index of DBKO Leydig cells was comparable to that of Cdkn1b knockout mice as previously reported [10] . This suggests that the Leydig cell in the DBKO mouse testis has a higher proliferative rate.
Testicular Testosterone Levels
Testicular testosterone concentrations were measured to reflect Leydig cell steroidogenesis. Testicular testosterone was not altered as calculated in whole testis in the Cdkn1a À/À and DBKO mouse testes (Fig. 3A ). However, testicular testosterone level was significantly lower in the DBKO mouse testis when calculated per milligram testis when compared to the WT mouse testis (Fig. 3B) . These data indicate that steroidogenesis in the DBKO testis is reduced.
Expression Levels of Testis Genes
The primary function of Leydig cells is to synthesize and secrete androgenic steroids under the stimulation of LH. Because serum LH levels were normal in Cdkn1a À/À and DBKO mice [20] , we measured mRNA levels of Leydig cellspecific genes. As shown in Figure 4 , after adjustment by Leydig cell numbers, only Lhcgr (encoding LHCGR for LH signaling) mRNA levels were significantly reduced in the Cdkn1a À/À mouse testis compared to the WT control. However, in the DBKO testis, Lhcgr, Scarb1 (encoding SR-RI for cholesterol transport into Leydig cells), Star (encoding StAR for cholesterol transport into mitochondria), Cyp11a1 (encoding cholesterol side-chain cleavage enzyme), Cyp17a1 (encoding CYP17A1 for the conversion from progesterone into androstenedione), and Hsd17b3 (encoding 17b-HSD3 for the conversion of androstenedione into testosterone) were significantly lower compared to the WT control. Hsd3b6 (encoding 3b-HSD for the conversion from pregnenolone into progesterone) and Insl3 (a Leydig cell-specific gene) were not changed in both Cdkn1a À/À and DBKO testes. The mRNA levels of Sertoli cell-specific genes (e.g., Fshr and Kitl) and the cell proliferation marker Pcna did not change in the Cdkn1a À/À and DBKO mice compared to the WT control. Thus, although overall Sertoli cell number is increased in both Cdkn1a À/À and DBKO mice [13] , relative concentrations of mRNA for Sertoli cell proteins appeared to be normal.
CDKN1A AND CDKN1B AFFECT LEYDIG CELLS
Cholesterol Transporter Proteins and Steroidogenic Enzyme Activities
Steroidogenic capacities of Leydig cells were evaluated by measuring the amounts of StAR and various steroidogenic enzymes activities in the testis. Significantly reduced amounts of LHCGR, StAR, and CYP11A1 were detected by Western blot analysis in the DBKO mouse testis (Fig. 5) . LHCGR was also lower in the Cdkn1a À/À testis. The protein levels of 3b-HSD, CYP17A1, and 17b-HSD3 were not changed in the Cdkn1a À/À testis. (Fig. 5) . We measured the enzyme activities of 3b-HSD, CYP17A1, and 17b-HSD3 and found these enzyme activities did not change in both Cdkn1a À/À and DBKO mouse testes (Fig. 6 ). However, SRD5A1 activity was not significant lower in the Cdkn1a À/À and DBKO testes (Fig.  6D) . These data indicate that the protein levels and enzyme activities followed the trends of their respective mRNA levels.
DISCUSSION
In the present study, we found increased numbers of Leydig cells in the DBKO testis but not in the Cdkn1a À/À testis. We also found hat significant lower testicular testosterone in the DBKO mouse testis but not in the Cdkn1a À/À testis. However, CDKN1A knockout also affected some differentiated function of Leydig cells-for example, the significant down-regulation of Lhcgr and thus its protein level.
The testis weight of the Cdkn1a À/À mouse was increased by 35%, which was comparable to that of the Cdkn1b À/À mouse (25%-38% increase compared to the WT control) [10, 13] . However, the testis weight of the DBKO mouse was 85% higher than that of the WT control, which is higher than that of either the Cdkn1a À/À or the Cdkn1b À/À mouse [13] . It is quite interesting that Leydig cell number in the Cdkn1a À/À testis was not increased (Fig. 1) , although the testis size was increased. Actually, the Leydig cell number per milligram testis was lower than that of the WT control (Fig. 1) . Although the increased expression of CDKN1A after overexpression of aryl hydrocarbon receptor is hypothesized to be associated with the inhibition of TM3 Leydig cell growth [11] , CDKN1A seems not to check the proliferation of Leydig cells in mice. This could be caused by the compensation of CDKN1B, because CDKN1B is available in the Leydig cells during the course of development. It is true that the DBKO mouse had significantly higher Leydig cell number (5.4 6 0.1 3 10 6 Leydig cells/ testis), which was comparable to that of the Cdkn1b À/À mouse (5.7 6 0.4 3 10 6 Leydig cells/testis) [10] . Calculated per milligram testis, the Leydig cell number in the DBKO mouse was comparable to the number in the WT control (Fig. 1D) , although that in the Cdkn1b À/À mouse was also observed to be significantly increased [10] . We also found that the labeling index of Leydig cells was not changed in the Cdkn1a À/À mouse testis but was significantly increased in the DBKO testis, which was comparable to the Cdkn1b À/À testis [10] . Therefore, we , and DBKO mice. A) Testis weight (mean 6 SEM, n ¼ 8). B and C) Leydig cell number (#; mean 6 SEM, n ¼ 3) as calculated in whole testis (B) or per milligram testis (C). D) Leydig cell average diameters (mean 6 SEM, n ¼ 8). *, **, and *** indicate significant difference compared to WT at P , 0.05, P , 0.01, and P , 0.001, respectively. Data showed that testis weights and Leydig cell numbers per testis in DBKO mice were increased.
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inferred that CDKN1A and CDKN1B disproportionally regulated the proliferation of testicular cells, with CDKN1A primarily regulating the proliferation of non-Leydig cells and CDKN1B primarily regulating the proliferation of Leydig cells. Our results also supported the hypothesis that CDKN1B was a major regulator of adult Leydig cell proliferation. CDKN1B normally serves to inhibit Leydig cell proliferation, and in the absence of CDKN1B, mitogenesis of adult Leydig cells will increase. The importance of CDKN1A and CDKN1B in cellcycle control has been shown by the observations of multiorgan hyperplasia and gigantism in Cdkn1b 
Cdkn1a
À/À mice [14, 21, 22 ]. An increased rate of Leydig cell tumors was not found in the DBKO mouse testis, although significant Leydig cell hyperplasia was noted.
In the Cdkn1a À/À mouse testis, testicular testosterone concentration was not reduced when calculated as testosterone production per milligram testis (Fig. 3) . Leydig cell number was significantly increased in the DBKO mouse testis, but À/À testis. C and F) DBKO testis. A-C) Low magnification. D-F) High magnification. G) Labeling index of Leydig cells (mean 6 SEM, n ¼ 4). Black arrow points to Leydig cells, which show brown cytosolic 3b-HSD staining. White arrow points to the labeled spermatogonial cell, which has dark nuclear BrdU staining. White arrowhead points to the labeled Leydig cell, which has dark nuclear BrdU staining. *** indicates a significant difference compared to WT at P , 0.001. Data showed that proliferative capacity of Leydig cell in DBKO mice was increased. Bar ¼ 10 lm.
CDKN1A AND CDKN1B AFFECT LEYDIG CELLS testicular testosterone was significantly reduced in DBKO mouse when expressed per milligram testis. The decrease in testosterone concentration appeared to result from impairments in multiple steps of the steroidogenic pathway. For example, we observed significant decreases in Lhcgr mRNA levels in the DBKO testis, whereas mRNA levels of Fshr and Kitl (both found in Sertoli cells) were unchanged. We also observed specific deficiencies in the Leydig cell steroidogenic pathway: Star, Cyp11a1, Cyp17a1, and Hsd17b3 mRNA levels and their respective protein levels or enzyme activities were significantly reduced in the DBKO mouse. Most importantly, the protein level of StAR, which is the rate-limiting step for ferrying cholesterol across the mitochondrial membrane [23] and providing the starting material for the steroidogenic pathway, was significantly lower in the DBKO mouse testis. Therefore, the lower testicular testosterone levels might largely be attributed to the decreased expression of Star in the DBKO mouse testis. The decreases of LHCGR, StAR, and CYP11A1 in DBKO mouse testis were similar to those in the Cdkn1b À/À mouse testis [10] . The decrease of CYP11A1 protein level followed the change of its mRNA levels in the DBKO mouse testis. Although we did not measure its activity, the CYP11A1 protein level usually represents its enzyme activity as shown in our previous study [24] . Interestingly, this decrease in steroidogenesis did not result from a global decrease in all steroidogenic enzymes, because the mRNA level and enzyme activity of 3b-HSD6 did not change. Thus, the steroidogenic lesions in the DBKO mice were selective rather than universal. The decease of 3b-HSD enzyme activity was a bit unexpected, because this enzyme normally is largely constitutive in the Leydig cells. We also observed a significant reduction of Lhcgr mRNA level in the Cdkn1a À/À mouse testis. However, unlike in the DBKO mouse testis, we did not observe any changes of StAR, CYP11A1, 3b-HSD, CYP17A1, and 17b-HSD3 protein levels or enzyme activities in the Cdkn1a À/À mouse testis. The unchanged level of StAR (the rate-limiting protein for steroidogenesis) in the Cdkn1a À/À mouse testis may explain the normal testicular testosterone level when compared to the WT control. The impaired LHCGR levels coupled with WT LH levels in the Cdkn1a À/À mice did not lead to lower levels of LH-dependent genes like Star and Cyp11a1, indicating that the reduction of LHCGR level did not reach the threshold to lead to the reduction of these genes.
The hypothalamus-pituitary axis is probably not involved in Cdkn1a
, and DBKO mice, because the serum LH level was unchanged [20] . Steroidogenesis was reduced only in the Cdkn1b À/À [10] and DBKO mouse testes. This suggests that in DBKO mice, the reduction of steroidogenesis was not caused by LH, and a direct inhibitory action of CDKN1B was possible. Therefore, it is reasonable to assign a role for both CDKN1A and CDKN1B in Leydig cell differentiation, because they specifically affect several key points in Leydig cell cholesterol transport and steroidogenesis. However, the role of CDKN1B in Leydig cell steroidogenesis is more important than that of CDKN1A. Thus, the role of CDKN1B in Leydig cell development appears to be consistent with that suggested by Bryja et al. [7] , who postulated a dual role for CDKN1B as a classical regulator of cell cycle via inhibition of CDKs and as a participant, in conjunction with Dtype cyclins, in the establishment and/or maintenance of differentiated status.
Sertoli cells have been reported to regulate the proliferation and differentiation of Leydig cells [2, 25] . For example, injections of follicle-stimulating hormone to animals with low or absent serum LH stimulated Leydig cell differentiation and steroidogenic activity [2] , and Sertoli cell androgen receptor knockout mice had reduced steroidogenic capacity [26] . Adult levels of CDKN1B are high in the testis and inversely correlate with rates of Sertoli cell proliferation during development [14] . Therefore, Cdkn1a and Cdkn1b knockout in Sertoli cells might have an impact on Leydig cell proliferation and differentiation. Although LH has been demonstrated to play a role in the Leydig cell hypertrophia, the unchanged serum LH level in Cdkn1a À/À mice could rule out the effects of LH. Other testicular cell types (e.g., Sertoli cells) are possibilities for this kind of hypertrophic effect on Leydig cells of Cdkn1a À/À mice. However, which Sertoli cell factors will be affected requires further investigation. Apparently, the possible Sertoli cell factor Kitl did not change in the Cdkn1a À/À and DBKO mice compared to the WT control.
In conclusion, the role of CDKN1B in controlling the cell cycle appears to be critical for Leydig cell proliferation, establishment of the adult Leydig cell population, and functional differentiation of Leydig cells, as indicated by their expression of steroidogenic enzymes and subsequent testosterone production. This suggests that the absence of CDKN1B may hold Leydig cells in the cell cycle longer and result in the , and DBKO mice. A) Testicular testosterone levels calculated as nanograms per whole testis. B) Testicular testosterone levels calculated as nanograms per milligram testis. Data are shown as the mean 6 SEM (n ¼ 5-6). ** indicates a significant difference compared to WT at P , 0.01. Data showed that testicular testosterone levels per milligram testis in DBKO mice were decreased.
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Leydig cells undergoing more extensive proliferation than in controls. Because Leydig cells normally express their full complement of steroidogenic enzymes and reach maximal testosterone production as they come out of the cell cycle and attain full differentiation, the present results indicate that the absence of CDKN1B may impair Leydig cell functional differentiation simply as a consequence of a greater proportion of Leydig cells being retained in the proliferative pool. However, CDKN1A seems not to be responsible for the proliferation check in Leydig cells. CDKN1A also seems to affect Leydig cell LH signaling and steroidogenesis, but less so than CDKN1B. , and DBKO mice. A-I) The mRNA levels of Leydig cell-specific genes (Lhcgr, Scarb1, Star, Cyp11a1, Hsd3b6, Cyp17a1, Hsd17b3, Srd5a1, and Insl3) were determined by qPCR, calculated relative to Rps16, and adjusted by 10 6 Leydig cells. Data are shown as the mean 6 SEM (n ¼ 4-6). Identical letters indicate no significant difference between two groups at P , 0.05. Data showed that the mRNA expression levels of Lhcgr, Scarb1, Star, Cyp11a1, Hsd3b6, Cyp17a1, and Hsd17b3 in DBKO testis were reduced, but only that of Lhcgr in Cdkn1a , and DBKO mice. The levels of LHCGR (A), StAR (B), CYP11A1 (C), 3b-HSD6 (D), CYP17A1 (E), and 17b-HSD3 (F) were determined by Western blot analysis, calculated relative to b-actin (ACTIN), and adjusted by 10 6 Leydig cells (mean 6 SEM, n ¼ 3). Identical letters indicate no significant difference between two groups at P , 0.05. Data showed that the protein levels of LHCGR, StAR, CYP11A1, 3b-HSD6, and CYP17A1 in DKO testis were reduced, but only that of LHCGR in Cdkn1a À/À testis was reduced.
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